Tivicay PD
NDC 49702-255, dolutegravir sodium, tablet, for suspension, from ViiV Healthcare Company.
- Product NDC
- 49702-255
- Status
- Listed
- Labeler
- ViiV Healthcare Company
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA213983
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49702-255 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOLUTEGRAVIR SODIUM5 mg/1
Pharmacologic classes
HIV Integrase Inhibitors [MoA]; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49702-255-37 | 49702025537 | 1 BOTTLE in 1 CARTON (49702-255-37) / 60 TABLET, FOR SUSPENSION in 1 BOTTLE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/63df5af3-b8ac-4e76-9830-2dbb340af922
Use it
Look up 49702-255 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49702-255 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49702-255. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.